Astellas and MBC BioLabs Announce 2019 Golden Ticket Competition
Astellas is offering up to two Golden Tickets for pioneering scientific research that complements Astellas' innovation initiatives. Of particular interest are companies working in oncology, immunology/allergy, neuromuscular disorders, sensory disorders and neuroscience.
Astellas Golden Ticket winners will gain access to:
One year's priority admission or renewal to MBC BioLabs state-of-the-art lab and Fast-Track Core facility
Astellas' R&D scientists, business leaders and global network partners
Atropos Therapeutics and Atomwise Launch Joint Venture to Discover Senescence Modulating Small Molecules for Cancer Patients
Atropos Therapeutics, Inc., a senescence platform discovery company based in MBC BioLabs San Carlos, and Atomwise Inc., a leader in artificial intelligence (AI) for drug discovery, announced that they will launch a joint venture company to discover and advance a pipeline of compounds for promising discovery targets for the treatment of cancer. Full Press Release.
Founders at Work Speaker Series with Mitokinin: "Amplifying PINK1 Kinase Activity to Cure Parkinson's Disease"
October 9, 2019 from 12:30 to 1:30 PM MBC BioLabs San Francisco
Please join CLSI at MBC Biolabs for the CLSI Startup Buzz Networking Event and come to learn about the FAST Advisory Program for Life Science Startups. California Life Sciences Institute (CLSI) supports the foundations of innovation that have made California home to the world's most prominent life sciences ecosystem. Their mission is to maintain California's leadership in life sciences innovation through support of entrepreneurship, education and career development. CLSI also serves as an accelerator for CARB-X, the world's largest public-private partnership devoted to early stage antibacterial R&D.
Larger Than Life Science: The Synthetic Future - Medicine, Food and Energy Transformed
October 30, 2019 from 3:30 AM to 6:30 PM MBC BioLabs San Carlos
Synthetic biology covers a lot of territory, from redesigning existing biological parts to build novel systems, to constructing a "simple" genome for medical, agricultural and industrial applications. The scientific field is attracting new talent and investment in part because of its potential to address some of the most vexing problems: How to convert from fossil fuels to a bio-based economy; how to produce food in more sustainable ways; how to create new precision medicine products. Join MBC BioLabs and LaunchBio to hear from investors and entrepreneurs about these technologies and how they will shape our lives. We'll also feature food samples of new plant-based proteins that look and taste like the real thing.